Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1977 1
1980 1
1981 5
1982 1
1983 2
1985 3
1986 1
1987 4
1988 3
1991 1
1992 2
1993 2
1994 9
1995 4
1996 3
1997 2
1998 3
1999 2
2000 3
2001 5
2002 8
2003 14
2004 9
2005 9
2006 18
2007 7
2008 10
2009 15
2010 9
2011 15
2012 13
2013 11
2014 13
2015 18
2016 17
2017 36
2018 27
2019 27
2020 33
2021 23
2022 32
2023 33
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

422 results

Results by year

Filters applied: . Clear all
Page 1
Takayasu phlebitis.
Katayama Y, Matsumoto Y, Yamamura Y, Asano Y, Hayashi K, Ohashi K, Morishita M, Watanabe H, Narazaki M, Sada KE, Wada J. Katayama Y, et al. Among authors: sada ke. Rheumatology (Oxford). 2020 Dec 1;59(12):e131-e133. doi: 10.1093/rheumatology/keaa333. Rheumatology (Oxford). 2020. PMID: 32617559 No abstract available.
Syk inhibitors.
Chihara K, Kimura Y, Honjo C, Takeuchi K, Sada K. Chihara K, et al. Among authors: sada k. Nihon Rinsho Meneki Gakkai Kaishi. 2013;36(4):197-202. doi: 10.2177/jsci.36.197. Nihon Rinsho Meneki Gakkai Kaishi. 2013. PMID: 23994797 Review. English, Japanese.
Amelioration of nephritis in receptor for advanced glycation end-products (RAGE)-deficient lupus-prone mice through neutrophil extracellular traps.
Watanabe H, Kubo M, Taniguchi A, Asano Y, Hiramatsu-Asano S, Ohashi K, Zeggar S, Katsuyama E, Katsuyama T, Sunahori-Watanabe K, Sada KE, Matsumoto Y, Yamamoto Y, Yamamoto H, Son M, Wada J. Watanabe H, et al. Among authors: sada ke. Clin Immunol. 2023 May;250:109317. doi: 10.1016/j.clim.2023.109317. Epub 2023 Apr 2. Clin Immunol. 2023. PMID: 37015317 Free PMC article.
Stabilization of microtubules by cevipabulin.
Nasrin SR, Rashedul Kabir AM, Konagaya A, Ishihara T, Sada K, Kakugo A. Nasrin SR, et al. Among authors: sada k. Biochem Biophys Res Commun. 2019 Aug 27;516(3):760-764. doi: 10.1016/j.bbrc.2019.06.095. Epub 2019 Jun 26. Biochem Biophys Res Commun. 2019. PMID: 31253401
Large vessel vasculitis with myelodysplastic syndrome.
Katsuyama T, Uchida HA, Toma K, Maeda Y, Hirota D, Umebayashi R, Sada KE, Makino H. Katsuyama T, et al. Among authors: sada ke. Intern Med. 2014;53(1):63-6. doi: 10.2169/internalmedicine.53.0949. Intern Med. 2014. PMID: 24390531 Free article. Review.
Current concept and epidemiology of systemic vasculitides.
Katsuyama T, Sada KE, Makino H. Katsuyama T, et al. Among authors: sada ke. Allergol Int. 2014 Dec;63(4):505-13. doi: 10.2332/allergolint.14-RAI-0778. Epub 2014 Oct 25. Allergol Int. 2014. PMID: 25339434 Free article. Review.
[Syk inhibitors].
Kimura Y, Chihara K, Takeuchi K, Sada K. Kimura Y, et al. Among authors: sada k. Nihon Rinsho. 2013 Jul;71(7):1248-52. Nihon Rinsho. 2013. PMID: 23961675 Review. Japanese.
MOONLIGHT study: the design of a comparative study of the effectiveness of belimumab in patients with a history of lupus nephritis from the post-Marketed effectiveness of belimumab cOhOrt and JapaN Lupus NatIonwide reGistry (LUNA) coHorT.
Sada K, Kurita N, Noma H, Matsuki T, Quasny H, Levy RA, Jones-Leone AR, Gairy K, Yajima N. Sada K, et al. Lupus Sci Med. 2022 Sep;9(1):e000746. doi: 10.1136/lupus-2022-000746. Lupus Sci Med. 2022. PMID: 37017254 Free PMC article.
422 results